Back to funds
View filing
Stonepine Capital Management, LLC
hedge fundUpdated 26 days agoManaged by Stonepine Capital Management, Llc • Latest filing Q2 2026
Portfolio value
$213.6M
Q2 2026
Filings
14
Quarterly 13F history
Top-10 concentration
78.5%
Weight of largest holdings
Annualized return
-16.3%
Implied from 13F holdings
Portfolio value history
13F-disclosed portfolio value over 14 quarters
Show data table
| Period | Portfolio value |
|---|---|
| Q1 2023 | $298.2M |
| Q2 2023 | $266.2M |
| Q3 2023 | $301M |
| Q4 2023 | $231.2M |
| Q1 2024 | $126.1M |
| Q2 2024 | $108.9M |
| Q3 2024 | $158.2M |
| Q4 2024 | $123.9M |
| Q1 2025 | $102.8M |
| Q2 2025 | $101.9M |
| Q3 2025 | $123M |
| Q4 2025 | $137M |
| Q1 2026 | $249.7M |
| Q2 2026 | $213.6M |
Top holdings
87 positions as of Q2 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | V VSTM VERASTEM INC | $12.8M | 3.35M | 7.22% | — |
| 2 | E EOLS EVOLUS INC | $11M | 1.59M | 6.23% | — |
| 3 | T TENX TENAX THERAPEUTICS INC | $9.6M | 660.0K | 5.42% | — |
| 4 | N NKTR NEKTAR THERAPEUTICS | $8.4M | 120.7K | 4.75% | — |
| 5 | A ADMA ADMA BIOLOGICS INC | $8M | 650.0K | 4.48% | — |
| 6 | A ADMA ADMA BIOLOGICS INC | $6.2M | 740.0K | 3.49% | — |
| 7 | C CAMP CAMP4 THERAPEUTICS CORP | $6.1M | 1.39M | 3.43% | — |
| 8 | I INSM INSMED INC | $5.6M | 40.0K | 3.16% | — |
| 9 | ? N/A ELOXX PHARMACEUTICALS INC | $5.5M | 397.2K | 3.11% | — |
| 10 | R RARE ULTRAGENYX PHARMACEUTICAL IN | $5.5M | 200.0K | 3.10% | — |
| 11 | K KZIA KAZIA THERAPEUTICS LTD | $4.9M | 345.2K | 2.74% | — |
| 12 | M MDT MEDTRONIC PLC | $4.4M | 50.0K | 2.47% | — |
| 13 | I INDV INDIVIOR PHARMACEUTICALS INC | $4.1M | 100.0K | 2.31% | — |
| 14 | C CRBP CORBUS PHARMACEUTICALS HLDGS | $4M | 425.0K | 2.25% | — |
| 15 | A ABT ABBOTT LABORATORIES | $3.8M | 40.0K | 2.14% | — |
| 16 | M MSLE SATELLOS BIOSCIENCE INC | $3.7M | 491.6K | 2.10% | — |
| 17 | J JPM-PM ZEVRA THERAPEUTICS INC | $3.7M | 258.7K | 2.09% | — |
| 18 | A ABEO ABEONA THERAPEUTICS INC | $3.4M | 557.3K | 1.94% | — |
| 19 | B BSX BOSTON SCIENTIFIC CORP | $3.3M | 50.0K | 1.83% | — |
| 20 | ? N/A EDESA BIOTECH INC | $3.2M | 456.4K | 1.80% | — |